-+ 0.00%
-+ 0.00%
-+ 0.00%

Market Chatter: UK Government to Consult Executives from AstraZeneca, GSK on New Drug Pricing Regime

MT Newswires·12/03/2025 00:19:21
Listen to the news
12:19 AM EST, 12/03/2025 (MT Newswires) -- The UK government intends to consult with executives from pharmaceutical companies, including AstraZeneca (AZN.L, AZN.ST) and GSK (GSK.L), as it formulates the new drug pricing regime, Sky News reported Tuesday, citing industry sources. The unnamed sources noted that the executives will be part of a new working group that will be established in the coming weeks. The working group will review various replacement options for the Voluntary Scheme for Branded Medicines Pricing and Access, which will expire in roughly three years. AstraZeneca and GSK did not immediately respond to requests for comments from MT Newswires. (Market Chatter news is derived from conversations with market professionals globally. This information is believed to be from reliable sources but may include rumor and speculation. Accuracy is not guaranteed.)